| Literature DB >> 36157282 |
Abstract
Over the past decade I, with collaborators, have authored a number of publications outlining what in the first of these I described as "Phage therapy best practices"-phage therapy being the use of bacterial viruses (bacteriophages) to treat bacterial infections, such as clinically. More generally, this is phage-mediated biocontrol of bacteria, including of bacteria that can contaminate foods. For the sake of increasing accessibility, here I gather some of these suggestions, along with some frustrations, into a single place, while first providing by way of explanation where they, and I, come from scientifically. Although in my opinion phage therapy and phage-mediated biocontrol are both sound approaches toward combating unwanted bacteria, I feel at the same time that the practice of especially phage therapy research could be improved. I supply also, as supplemental material, a list of ∼100 English language 2000-and-later publications providing primary descriptions of phage application to humans. Copyright 2022, Mary Ann Liebert, Inc., publishers.Entities:
Keywords: antibacterial; antibiotic; bacteriophage therapy; biological control
Year: 2022 PMID: 36157282 PMCID: PMC9436250 DOI: 10.1089/phage.2022.0012
Source DB: PubMed Journal: Phage (New Rochelle) ISSN: 2641-6530